Joltoo
Grants
Browse catalogTailored listsFind your matchesFundersPrograms
InvestorsAdvisoryInsights
DeepTech 2026 PlaybookRequest access
Browse all
  1. Home
  2. /Investors
  3. /Biotech
  4. /Foresite Capital
Foresite Capital

Foresite Capital

DeepTech NativeSan Francisco, United StatesActiveWebsiteLinkedIn
Stage FocusSeed, Series A, Series B+
GeographyUS
TypeVC
Last Activity2025
Industry Focus
Industries
BiotechMedtechAI
Technical BenchStrong
Investor TypeDeepTech Specialist
ExposureMostly DeepTech Investments
Bio

Foresite Capital, founded in 2011 by Jim Tananbaum MD, manages $3.5B-plus—making it one of the largest dedicated healthcare and life sciences VCs. Fund VI closed at $900M in June 2024. Check sizes range from $2M to $75M, backing approximately 20 companies per fund through the full investment lifecycle.

The portfolio demonstrates deep tech conviction in genomics and precision medicine: 10x Genomic...

Notable Investments
1
10x Genomics
R
Relay Therapeutics
V
Vaxcyte
J
Juno Therapeutics
I
Intellia Therapeutics
P
Pacific Biosciences
Q
Quantum-SI

Similar Funds

ARTIS Ventures

ARTIS Ventures

San Francisco, United States

DeepTech NativeBiotechAIMedtechSeedSeries A
C

Compound

New York, United States

DeepTech NativeBiotechAIRoboticsPre-SeedSeed
ED

Emerald Development Managers

United States

DeepTech NativeBiotechCybersecurityAdvanced MaterialsSeedSeries A
Osage University Partners

Osage University Partners

Bala Cynwyd, United States

DeepTech NativeBiotechMedtechClimate TechSeedSeries A
Section 32 (S32)

Section 32 (S32)

Palo Alto, United States

DeepTech NativeBiotechMedtechAISeedSeries A
S

SmartGateVC

Yerevan, Armenia

DeepTech NativeBiotechNeurotechAIPre-SeedSeed
Work at Foresite Capital? Claim this page
Joltoo
PricingInsightsTailored lists
Privacy PolicyTerms of Service
Security
© 2026 Joltoo. All rights reserved.